Spinraza: The criteria will be expanded in Quebec/Canada

to include patients who: are pre-symptomatic with two or three copies of SMN2 gene; or have had disease duration of less than six months, two copies of the SMN2 gene, and symptom onset after the first week after birth and on or before seven months of age; or are under the age of 18 with … Fortsätt läsa Spinraza: The criteria will be expanded in Quebec/Canada